24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
38.44% |
|
ALZHEIMERS |
18.34% |
|
PEPTIDOMIMETIC CD40L BINDING |
13.57% |
|
CANCER |
10.3% |
|
EBOLA |
9.8% |
|
RCA TEMPERATURE SIMULATIONS |
5.03% |
|
PLANT LIPID MUTANT SCREENING |
4.52% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
46.67% |
|
ENZYME DYNAMICS |
18.81% |
|
CANCER |
10.56% |
|
PEPTIDOMIMETIC CD40L BINDING |
10.52% |
|
EBOLA |
7.97% |
|
RCA TEMPERATURE SIMULATIONS |
3.51% |
|
PLANT LIPID MUTANT SCREENING |
1.12% |
|
ATSTP10 TRANSPORT SIMULATION |
.52% |
|
GRASPETIDE RING FORMATION |
.32% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
42.66% |
|
ENZYME DYNAMICS |
14.14% |
|
PEPTIDOMIMETIC CD40L BINDING |
9.55% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
8.99% |
|
CANCER |
8.25% |
|
EBOLA |
6.18% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
3.1% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
1.59% |
|
RCA TEMPERATURE SIMULATIONS |
1.4% |
|
ATSTP10 SUCROSE TRANSPORT |
1.36% |
|
ATSTP10 TRANSPORT SIMULATION |
1.03% |
|
RCA STABILITY SIMULATIONS |
.54% |
|
SUCROSE TRANSPORTER ATSUC1 |
.29% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.21% |
|
PLANT LIPID MUTANT SCREENING |
.21% |
|
GRASPETIDE RING FORMATION |
.17% |
|
ATWRI1 MUTANT SCREENING |
.15% |
|
MEMBRANE TRANSPORT |
.15% |
|
NIPAH VIRUS DECOY PROTEINS |
.05% |